Does HCSC cover Zepbound?

Yes. HCSC covers Zepbound for obstructive sleep apnea (OSA) with prior authorization if your BMI is 30 or higher. Other policy requirements and your plan's benefits also apply.

How long does a Zepbound approval last with HCSC?

Obstructive Sleep Apnea (OSA) — Applies to Employer plans. Initial approval: 12 months. Renewal: every 12 months.

What does HCSC require to renew Zepbound?

Obstructive Sleep Apnea (OSA) — Applies to Employer plans. At renewal for OSA indication: patient must have had clinical benefit with Zepbound (e.g., reduction in AHI, decrease in Epworth Sleepiness Scale). Initial AHI ≥ 15 and BMI ≥ 30 requirements are not explicitly re-verified at renewal.

How current is this information?

The oldest review date among the policies on this page is June 2, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

HCSC coverage for Zepbound (Obstructive Sleep Apnea

Applies to Employer plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

OSA with obesity

All of:

Diagnosis of obstructive sleep apnea (OSA) confirmed by medical records
Patient has had a polysomnography (PSG) or home sleep apnea test
AHI ≥ 15 events/hour from baseline (prior to initiation of pharmacotherapy)
Requested agent is Zepbound
Pretreatment BMI ≥ 30 kg/m2
Patient does NOT have any FDA labeled contraindications

Documentation to bring

Medical records confirming diagnosis of obstructive sleep apnea (OSA)
Polysomnography (PSG) or home sleep apnea test results
Documentation of AHI ≥ 15 events/hour from baseline (prior to initiation of pharmacotherapy)
Baseline BMI documentation (≥ 30 kg/m2)
For renewal: documentation of clinical benefit (e.g., reduction in AHI, decrease in Epworth Sleepiness Scale)

Quantity limits

2.5 MG/0.5ML vial — 2 mL per 180-day supply (84-day)
5 MG/0.5ML vial — 2 mL per 28-day supply
7.5 MG/0.5ML vial, 10 MG/0.5ML vial, 12.5 MG/0.5ML vial, 15 MG/0.5ML vial — 4 vials per 28-day supply
2.5 MG/0.5ML autoinjector — 4 pens per 180-day supply (84-day)
5 MG/0.5ML autoinjector, 7.5 MG/0.5ML autoinjector, 10 MG/0.5ML autoinjector, 12.5 MG/0.5ML autoinjector, 15 MG/0.5ML autoinjector — 4 pens per 28-day supply
2.5 MG/0.6ML kwikpen — 1 pen per 180-day supply (84-day)
5 MG/0.6ML kwikpen, 7.5 MG/0.6ML kwikpen, 10 MG/0.6ML kwikpen, 12.5 MG/0.6ML kwikpen, 15 MG/0.6ML kwikpen — 1 pen per 28-day supply

Approval and renewal

Initial approval: 12 months
Renewal: every 12 months
Renewal: At renewal for OSA indication: patient must have had clinical benefit with Zepbound (e.g., reduction in AHI, decrease in Epworth Sleepiness Scale). Initial AHI ≥ 15 and BMI ≥ 30 requirements are not explicitly re-verified at renewal.

Not covered when

AHI < 15 events/hour
Any FDA labeled contraindications to the requested agent

Exceptions

BCBS_NM_Fully_Insured_or_HIM: May be approved if patient does not have FDA labeled contraindications AND the requested indication is a rare disease AND patient has another FDA labeled indication or compendia-supported indication.
Ohio_Fully_Insured_or_HIM_SHOP: May be approved if member resides in Ohio, plan is Fully Insured or HIM Shop (SG), no FDA labeled contraindications, AND patient has another FDA labeled or compendia-supported indication OR prescriber submits two articles from major peer-reviewed journals.

Policy note: No PAP/CPAP trial requirement stated. AHI must be ≥ 15 events/hour from baseline prior to initiation of pharmacotherapy. OSA diagnosis requires medical records. Renewal requires clinical benefit demonstrated (examples: reduction in AHI, decrease in Epworth Sleepiness Scale). Policy applies to all Zepbound formulations (vial, autoinjector, kwikpen).

Policy effective May 18, 2026 · verified June 2, 2026 · source: Hcsc Weight Management Prog Sum · View policy document (PDF)

Does HCSC cover Zepbound for Obstructive Sleep Apnea (OSA)?

Policy document